PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $394,000 | -45.3% | 7,500 | -52.8% | 0.29% | +657.9% |
| Q4 2019 | $720,000 | -41.7% | 15,886 | -51.1% | 0.04% | -41.5% |
| Q3 2019 | $1,236,000 | -6.2% | 32,475 | +7.3% | 0.06% | -5.8% |
| Q2 2019 | $1,317,000 | +327.6% | 30,275 | +382.5% | 0.07% | +263.2% |
| Q3 2018 | $308,000 | +569.6% | 6,275 | +555.7% | 0.02% | +171.4% |
| Q2 2017 | $46,000 | -41.0% | 957 | -60.1% | 0.01% | -56.2% |
| Q4 2016 | $78,000 | -71.1% | 2,401 | -69.6% | 0.02% | -79.7% |
| Q3 2016 | $270,000 | +321.9% | 7,901 | +315.6% | 0.08% | +259.1% |
| Q2 2016 | $64,000 | +3.2% | 1,901 | +137.3% | 0.02% | -47.6% |
| Q4 2015 | $62,000 | – | 801 | +80000.0% | 0.04% | – |
| Q3 2015 | $0 | -100.0% | 1 | -99.8% | 0.00% | -100.0% |
| Q1 2015 | $53,000 | -100.0% | 601 | -82.8% | 0.09% | -66.2% |
| Q3 2014 | $339,317,000 | +47893.9% | 3,501 | -65.3% | 0.26% | -57.4% |
| Q1 2014 | $707,000 | – | 10,100 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |